Urinary MicroRNAs of Prostate Cancer: Virus-Encoded hsv1-miRH18 and hsv2-miR-H9-5p Could Be Valuable Diagnostic Markers

Purpose: MicroRNAs (miRNAs) in biological fluids are potential biomarkers for the diagnosis and assessment of urological diseases such as benign prostatic hyperplasia (BPH) and prostate cancer (PCa). The aim of the study was to identify and validate urinary cell-free miRNAs that can segregate patien...

Full description

Bibliographic Details
Main Authors: Seok Joong Yun, Pildu Jeong, Ho Won Kang, Ye-Hwan Kim, Eun-Ah Kim, Chunri Yan, Young-Ki Choi, Dongho Kim, Jung Min Kim, Seon-Kyu Kim, Seon-Young Kim, Sang Tae Kim, Won Tae Kim, Ok-Jun Lee, Gou-Young Koh, Sung-Kwon Moon, Isaac Yi Kim, Jayoung Kim, Yung-Hyun Choi, Wun-Jae Kim
Format: Article
Language:English
Published: Korean Continence Society 2015-06-01
Series:International Neurourology Journal
Subjects:
Online Access:http://www.einj.org/upload/pdf/inj-19-2-74.pdf
id doaj-ffdea2b14603437c9661c2ff942af161
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Seok Joong Yun
Pildu Jeong
Ho Won Kang
Ye-Hwan Kim
Eun-Ah Kim
Chunri Yan
Young-Ki Choi
Dongho Kim
Jung Min Kim
Seon-Kyu Kim
Seon-Young Kim
Sang Tae Kim
Won Tae Kim
Ok-Jun Lee
Gou-Young Koh
Sung-Kwon Moon
Isaac Yi Kim
Jayoung Kim
Yung-Hyun Choi
Wun-Jae Kim
spellingShingle Seok Joong Yun
Pildu Jeong
Ho Won Kang
Ye-Hwan Kim
Eun-Ah Kim
Chunri Yan
Young-Ki Choi
Dongho Kim
Jung Min Kim
Seon-Kyu Kim
Seon-Young Kim
Sang Tae Kim
Won Tae Kim
Ok-Jun Lee
Gou-Young Koh
Sung-Kwon Moon
Isaac Yi Kim
Jayoung Kim
Yung-Hyun Choi
Wun-Jae Kim
Urinary MicroRNAs of Prostate Cancer: Virus-Encoded hsv1-miRH18 and hsv2-miR-H9-5p Could Be Valuable Diagnostic Markers
International Neurourology Journal
Prostate Cancer
Urine
Herpes Simplex
MicroRNA
author_facet Seok Joong Yun
Pildu Jeong
Ho Won Kang
Ye-Hwan Kim
Eun-Ah Kim
Chunri Yan
Young-Ki Choi
Dongho Kim
Jung Min Kim
Seon-Kyu Kim
Seon-Young Kim
Sang Tae Kim
Won Tae Kim
Ok-Jun Lee
Gou-Young Koh
Sung-Kwon Moon
Isaac Yi Kim
Jayoung Kim
Yung-Hyun Choi
Wun-Jae Kim
author_sort Seok Joong Yun
title Urinary MicroRNAs of Prostate Cancer: Virus-Encoded hsv1-miRH18 and hsv2-miR-H9-5p Could Be Valuable Diagnostic Markers
title_short Urinary MicroRNAs of Prostate Cancer: Virus-Encoded hsv1-miRH18 and hsv2-miR-H9-5p Could Be Valuable Diagnostic Markers
title_full Urinary MicroRNAs of Prostate Cancer: Virus-Encoded hsv1-miRH18 and hsv2-miR-H9-5p Could Be Valuable Diagnostic Markers
title_fullStr Urinary MicroRNAs of Prostate Cancer: Virus-Encoded hsv1-miRH18 and hsv2-miR-H9-5p Could Be Valuable Diagnostic Markers
title_full_unstemmed Urinary MicroRNAs of Prostate Cancer: Virus-Encoded hsv1-miRH18 and hsv2-miR-H9-5p Could Be Valuable Diagnostic Markers
title_sort urinary micrornas of prostate cancer: virus-encoded hsv1-mirh18 and hsv2-mir-h9-5p could be valuable diagnostic markers
publisher Korean Continence Society
series International Neurourology Journal
issn 2093-4777
2093-6931
publishDate 2015-06-01
description Purpose: MicroRNAs (miRNAs) in biological fluids are potential biomarkers for the diagnosis and assessment of urological diseases such as benign prostatic hyperplasia (BPH) and prostate cancer (PCa). The aim of the study was to identify and validate urinary cell-free miRNAs that can segregate patients with PCa from those with BPH. Methods: In total, 1,052 urine, 150 serum, and 150 prostate tissue samples from patients with PCa or BPH were used in the study. A urine-based miRNA microarray analysis suggested the presence of differentially expressed urinary miRNAs in patients with PCa, and these were further validated in three independent PCa cohorts, using a quantitative reverse transcriptionpolymerase chain reaction analysis. Results: The expression levels of hsa-miR-615-3p, hsv1-miR-H18, hsv2-miR-H9-5p, and hsa-miR-4316 were significantly higher in urine samples of patients with PCa than in those of BPH controls. In particular, herpes simplex virus (hsv)-derived hsv1-miR-H18 and hsv2-miR-H9-5p showed better diagnostic performance than did the serum prostate-specific antigen (PSA) test for patients in the PSA gray zone. Furthermore, a combination of urinary hsv2-miR-H9-5p with serum PSA showed high sensitivity and specificity, providing a potential clinical benefit by reducing unnecessary biopsies. Conclusions: Our findings showed that hsv-encoded hsv1-miR-H18 and hsv2-miR-H9-5p are significantly associated with PCa and can facilitate early diagnosis of PCa for patients within the serum PSA gray zone.
topic Prostate Cancer
Urine
Herpes Simplex
MicroRNA
url http://www.einj.org/upload/pdf/inj-19-2-74.pdf
work_keys_str_mv AT seokjoongyun urinarymicrornasofprostatecancervirusencodedhsv1mirh18andhsv2mirh95pcouldbevaluablediagnosticmarkers
AT pildujeong urinarymicrornasofprostatecancervirusencodedhsv1mirh18andhsv2mirh95pcouldbevaluablediagnosticmarkers
AT howonkang urinarymicrornasofprostatecancervirusencodedhsv1mirh18andhsv2mirh95pcouldbevaluablediagnosticmarkers
AT yehwankim urinarymicrornasofprostatecancervirusencodedhsv1mirh18andhsv2mirh95pcouldbevaluablediagnosticmarkers
AT eunahkim urinarymicrornasofprostatecancervirusencodedhsv1mirh18andhsv2mirh95pcouldbevaluablediagnosticmarkers
AT chunriyan urinarymicrornasofprostatecancervirusencodedhsv1mirh18andhsv2mirh95pcouldbevaluablediagnosticmarkers
AT youngkichoi urinarymicrornasofprostatecancervirusencodedhsv1mirh18andhsv2mirh95pcouldbevaluablediagnosticmarkers
AT donghokim urinarymicrornasofprostatecancervirusencodedhsv1mirh18andhsv2mirh95pcouldbevaluablediagnosticmarkers
AT jungminkim urinarymicrornasofprostatecancervirusencodedhsv1mirh18andhsv2mirh95pcouldbevaluablediagnosticmarkers
AT seonkyukim urinarymicrornasofprostatecancervirusencodedhsv1mirh18andhsv2mirh95pcouldbevaluablediagnosticmarkers
AT seonyoungkim urinarymicrornasofprostatecancervirusencodedhsv1mirh18andhsv2mirh95pcouldbevaluablediagnosticmarkers
AT sangtaekim urinarymicrornasofprostatecancervirusencodedhsv1mirh18andhsv2mirh95pcouldbevaluablediagnosticmarkers
AT wontaekim urinarymicrornasofprostatecancervirusencodedhsv1mirh18andhsv2mirh95pcouldbevaluablediagnosticmarkers
AT okjunlee urinarymicrornasofprostatecancervirusencodedhsv1mirh18andhsv2mirh95pcouldbevaluablediagnosticmarkers
AT gouyoungkoh urinarymicrornasofprostatecancervirusencodedhsv1mirh18andhsv2mirh95pcouldbevaluablediagnosticmarkers
AT sungkwonmoon urinarymicrornasofprostatecancervirusencodedhsv1mirh18andhsv2mirh95pcouldbevaluablediagnosticmarkers
AT isaacyikim urinarymicrornasofprostatecancervirusencodedhsv1mirh18andhsv2mirh95pcouldbevaluablediagnosticmarkers
AT jayoungkim urinarymicrornasofprostatecancervirusencodedhsv1mirh18andhsv2mirh95pcouldbevaluablediagnosticmarkers
AT yunghyunchoi urinarymicrornasofprostatecancervirusencodedhsv1mirh18andhsv2mirh95pcouldbevaluablediagnosticmarkers
AT wunjaekim urinarymicrornasofprostatecancervirusencodedhsv1mirh18andhsv2mirh95pcouldbevaluablediagnosticmarkers
_version_ 1725590090710777856
spelling doaj-ffdea2b14603437c9661c2ff942af1612020-11-24T23:15:38ZengKorean Continence SocietyInternational Neurourology Journal2093-47772093-69312015-06-01192748410.5213/inj.2015.19.2.74524Urinary MicroRNAs of Prostate Cancer: Virus-Encoded hsv1-miRH18 and hsv2-miR-H9-5p Could Be Valuable Diagnostic MarkersSeok Joong Yun0Pildu Jeong1Ho Won Kang2Ye-Hwan Kim3Eun-Ah Kim4Chunri Yan5Young-Ki Choi6Dongho Kim7Jung Min Kim8Seon-Kyu Kim9Seon-Young Kim10Sang Tae Kim11Won Tae Kim12Ok-Jun Lee13Gou-Young Koh14Sung-Kwon Moon15Isaac Yi Kim16Jayoung Kim17Yung-Hyun Choi18Wun-Jae Kim19 Department of Urology, Chungbuk National University College of Medicine, Cheongju, Korea Department of Urology, Chungbuk National University College of Medicine, Cheongju, Korea Department of Urology, Chungbuk National University College of Medicine, Cheongju, Korea Department of Urology, Chungbuk National University College of Medicine, Cheongju, Korea Department of Urology, Chungbuk National University College of Medicine, Cheongju, Korea Department of Urology, Chungbuk National University College of Medicine, Cheongju, Korea Department of Microbiology, College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju, Korea Bio Medical Laboratories (BML), Daejeon, Korea NAR Center Inc., Daejeon Oriental Hospital of Daejeon University, Daejeon, Korea Medical Genomics Research Center, Korean Bioinformation Center, Korea Research Institute of Bioscience and Biotechnology, Department of Functional Genomics, University of Science and Technology, Daejeon, Korea Medical Genomics Research Center, Korean Bioinformation Center, Korea Research Institute of Bioscience and Biotechnology, Department of Functional Genomics, University of Science and Technology, Daejeon, Korea Biomedical Research Institute, Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea Department of Urology, Chungbuk National University College of Medicine, Cheongju, Korea Department of Pathology, Chungbuk National University College of Medicine, Cheongju, Korea National Research Laboratory of Vascular Biology and Stem Cells, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Korea School of Food Science and Technology, Chung-Ang University, Anseong, Korea The Section of Urologic Oncology and Dean and Betty Gallo Prostate Cancer Center, The Cancer Institute of New Jersey, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ, USA Department of Surgery, Harvard Medical School, Boston, MA, USA Department of Biochemistry, Dongeui University College of Oriental Medicine, Busan, Korea Department of Urology, Chungbuk National University College of Medicine, Cheongju, KoreaPurpose: MicroRNAs (miRNAs) in biological fluids are potential biomarkers for the diagnosis and assessment of urological diseases such as benign prostatic hyperplasia (BPH) and prostate cancer (PCa). The aim of the study was to identify and validate urinary cell-free miRNAs that can segregate patients with PCa from those with BPH. Methods: In total, 1,052 urine, 150 serum, and 150 prostate tissue samples from patients with PCa or BPH were used in the study. A urine-based miRNA microarray analysis suggested the presence of differentially expressed urinary miRNAs in patients with PCa, and these were further validated in three independent PCa cohorts, using a quantitative reverse transcriptionpolymerase chain reaction analysis. Results: The expression levels of hsa-miR-615-3p, hsv1-miR-H18, hsv2-miR-H9-5p, and hsa-miR-4316 were significantly higher in urine samples of patients with PCa than in those of BPH controls. In particular, herpes simplex virus (hsv)-derived hsv1-miR-H18 and hsv2-miR-H9-5p showed better diagnostic performance than did the serum prostate-specific antigen (PSA) test for patients in the PSA gray zone. Furthermore, a combination of urinary hsv2-miR-H9-5p with serum PSA showed high sensitivity and specificity, providing a potential clinical benefit by reducing unnecessary biopsies. Conclusions: Our findings showed that hsv-encoded hsv1-miR-H18 and hsv2-miR-H9-5p are significantly associated with PCa and can facilitate early diagnosis of PCa for patients within the serum PSA gray zone.http://www.einj.org/upload/pdf/inj-19-2-74.pdfProstate CancerUrineHerpes SimplexMicroRNA